The True Cost of Manufacturing Novo Nordisk's Ozempic Revealed in New Study
Wednesday, 27 March 2024, 16:55
The study on Novo Nordisk's Ozempic manufacturing costs
Researchers have revealed that Novo Nordisk's diabetes drug, Ozempic, could be produced for as low as 89 cents to $4.73 per month, with a profit margin included.
Implications for the pharmaceutical industry
The findings highlight the stark contrast between manufacturing costs and market prices, raising concerns about drug pricing strategies.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.